CHEMED CORP
CHEdata completeness 88%18 fiscal years on fileCHEMED CORP earns about 30% on invested capital, far above its ~9% cost of capital, and has bought back 9% of its shares over 5 years — the marks of a durable business run for its owners. The estimate methods put fair value between $192.46 and $584.17 a share.Whether it’s worth owning at today’s price is the last question — and yours to answer, below.
| Figure | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|
| Revenue | $1.26B1 | $1.2B2 | $1.32B2 | $1.53B2 | $2.53B3 |
| Net income | $268.6M4 | $249.6M5 | $272.5M6 | $302M6 | $265.2M6 |
| Operating cash flow | $308.6M7 | $309.9M8 | $330.3M9 | $417.5M9 | $388.3M9 |
| Capital expenditure | $58.7M10 | $57.3M11 | $56.9M12 | $49.5M12 | $62.8M12 |
| Free cash flow (derived) | $249.9M7 | $252.6M8 | $273.4M9 | $368M9 | $325.5M9 |
| Total debt | $370M13 | $195M14 | — | — | — |
| Cash & equivalents | $32.9M15 | $74.1M16 | $264M17 | $178.4M18 | $74.5M18 |
| Diluted shares | 15.9M | 15.1M | 15.2M | 15.2M | 14.5M |
Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom).
10 shares is a claim on $677.32 of net worth that earned you $183.43 and generated $225.09 of cash last year.
It earned about 30% on invested capital, year after year, against a ~9% cost of capital — the footprint of real pricing power. Competition usually drags returns like this back down; here it hasn't.
seeing a moat in the numbers →Share count is down 9% over 5 years — management has been buying back stock, quietly handing owners a bigger slice. Total debt has fallen 47% — deleveraging.
reading capital allocation →Signals, not verdicts — read from the filings above. Numbers don’t prove a moat; they show its footprint. You decide.
The 3 estimate methods that apply put fair value between $192.46 and $584.17 a share. They rest on different assumptions, so where they diverge is the story; the Graham Number is a stricter floor, not a target.
assumptions (10)
- riskFreeRate4.7%
- equityRiskPremium5.0%
- beta100.0%
- equityWeight85.0%
- costOfDebtSpread1.5%
- taxRate21.0%
- terminalGrowth2.5%
- projectionYears10
- fcfGrowth8.8%
- fcfBase$325.5M
assumptions (10)
- riskFreeRate4.7%
- equityRiskPremium5.0%
- beta100.0%
- equityWeight85.0%
- costOfDebtSpread1.5%
- taxRate21.0%
- terminalGrowth2.5%
- projectionYears5
- fcfGrowth8.8%
- fcfBase$325.5M
assumptions (8)
- riskFreeRate4.7%
- equityRiskPremium5.0%
- beta100.0%
- equityWeight85.0%
- costOfDebtSpread1.5%
- taxRate21.0%
- normalizedEarnings$268.6M
- growthAssumed0.0%
assumptions (1)
- grahamMultiplier2250.0%
Different models answer different questions — which to trust when →
| Bear | 0.0% | $326.75 |
| Base | 8.8% | $474.31 |
| Bull | 13.8% | $580.64 |
Bear/base/bull growth = 0% / filed history / history + 5pp. Type a price to see the return each case implies.
Default growth 8.8%= this company’s own filed history (median-to-median FCF CAGR, clamped 0–20%). Your adjustments are recorded anonymously. They become the “what do owners actually believe” dataset.
- 10-K · period ending 2021-12-31 · accession 0001562762-24-000045 (RevenueFromContractWithCustomerExcludingAssessedTax)
- 10-K · period ending 2022-12-31 · accession 0001562762-25-000038 (RevenueFromContractWithCustomerExcludingAssessedTax)
- 10-K · period ending 2025-12-31 · accession 0001562762-26-000020 (Revenues)
- 10-K · period ending 2021-12-31 · accession 0001562762-24-000045 (NetIncomeLoss)
- 10-K · period ending 2022-12-31 · accession 0001562762-25-000038 (NetIncomeLoss)
- 10-K · period ending 2023-12-31 · accession 0001562762-26-000020 (NetIncomeLoss)
- 10-K · period ending 2021-12-31 · accession 0001562762-24-000045 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2022-12-31 · accession 0001562762-25-000038 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2023-12-31 · accession 0001562762-26-000020 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2021-12-31 · accession 0001562762-24-000045 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2022-12-31 · accession 0001562762-25-000038 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2023-12-31 · accession 0001562762-26-000020 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2021-12-31 · accession 0001562762-23-000057 (LongTermDebtNoncurrent)
- 10-K · period ending 2022-12-31 · accession 0001562762-24-000045 (LongTermDebtNoncurrent)
- 10-K · period ending 2021-12-31 · accession 0001562762-23-000057 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2022-12-31 · accession 0001562762-24-000045 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2023-12-31 · accession 0001562762-25-000038 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2024-12-31 · accession 0001562762-26-000020 (CashAndCashEquivalentsAtCarryingValue)